Publications (90) Mario Riverol Fernández publications

filter_list

2025

  1. Combination of amyloid and FDG PET for the prediction of short-term conversion from MCI to Alzheimer´s disease in the clinical practice

    European Journal of Nuclear Medicine and Molecular Imaging

2024

  1. Clinical Manifestations

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 20, pp. e089217

  2. Clusters of cognitive performance predict long-term cognitive impairment in elderly patients with subjective memory complaints and healthy controls

    Alzheimer's and Dementia, Vol. 20, Núm. 7, pp. 4702-4716

  3. Magnetic Resonance-Guided Focused Ultrasound (MRgFUS)-Thalamotomy for Essential Tremor: Lesion Location and Clinical Outcomes

    Movement Disorders, Vol. 39, Núm. 6, pp. 1015-1025

  4. Neuropsychological differences in Alzheimer's disease depending on the age of onset

    Revista Espanola de Geriatria y Gerontologia, Vol. 59, Núm. 1

  5. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease, Vol. 11, Núm. 5, pp. 1212-1218

  6. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample

    NeuroImage: Clinical, Vol. 42

2023

  1. Medical help-seeking intentions among patients with early Alzheimer’s disease

    Frontiers in Psychiatry, Vol. 14

  2. Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning

    Journal of Alzheimer's disease : JAD, Vol. 93, Núm. 1, pp. 125-140

2022

  1. Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192

  2. Grey matter changes on brain MRI in subjective cognitive decline: a systematic review

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  3. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease

    Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726

  4. Supplementary Information for Grey matter changes on brain MRI in subjective cognitive decline: a systematic review

    Grey matter changes on brain MRI in subjective cognitive decline: a systematic review

2021

  1. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

    International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333

  2. Blood pressure and risk of cognitive impairment: The role of vascular disease in neurodegeneration

    Brain Sciences, Vol. 11, Núm. 3

  3. Caso 28. Evaluación del paciente mayor

    Manual de casos con pacientes estandarizados para el ECOE (Editorial Médica Panamericana), pp. 88-89

  4. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  5. Psychosocial Adjustment to Illness Scale in family caregivers of patients with Parkinson’s Disease: Spanish validation study

    Health and Social Care in the Community, Vol. 29, Núm. 4, pp. 1030-1040

  6. [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 3, pp. 947-948

2020

  1. 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results

    Diagnostics, Vol. 10, Núm. 6